SCHEMBL4911972

SCHEMBL4911972

Cc1cc(-c2ccc(C#N)cc2)c[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.47
MMP3 P08254 1/20 0.47
ALDH1A1 P00352 2/20 0.46
CYP2A6 P11509 2/20 0.46
RIPK1 Q13546 1/20 0.42
MCL1 Q07820 3/20 0.42
CCNC P24863 1/20 0.42
CDK8 P49336 1/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
GAA P10253 1/20 0.40
CYP11B2 P19099 2/20 0.39
KIT P10721 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28249917 0.78 MMP3 (0.45) KIF11MMP3ALDH1A1CYP2A6RIPK1
SCHEMBL28280408 0.76 HMBS (0.48) ALDH1A1MCL1GAA
SCHEMBL27450425 0.75 NOTUM (0.45) KIF11MMP3ALDH1A1RIPK1MCL1
Water SCHEMBL11055485 0.75 MMP3 (0.74) KIF11MMP3ALDH1A1CYP2A6CA12
SCHEMBL396846 0.75 MMP3 (0.74) KIF11MMP3ALDH1A1CYP2A6CA12
SCHEMBL13063633 0.75 MMP3 (0.74) KIF11MMP3ALDH1A1CYP2A6CA12
SCHEMBL26246 0.75 MMP3 (0.74) KIF11MMP3ALDH1A1CYP2A6CA12
SCHEMBL27643249 0.74 ERCC1 (0.55) ALDH1A1KDM4E
SCHEMBL12377032 0.73 CYP2A6 (0.84) KIF11MMP3ALDH1A1CYP2A6CA12
Water SCHEMBL28512959 0.73 CYP2A6 (0.84) KIF11MMP3ALDH1A1CYP2A6CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190713-A1 FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF WUXI APPTEC (HONG KONG) CO., LIMITED (HK) 2017-07-06 US disclosed
US-20080176906-A1 Substituted Pyrrole Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 US disclosed
US-20080176906-A1 Substituted Pyrrole Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 US disclosed
US-20080176906-A1 Substituted Pyrrole Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-24 US disclosed
WO-2007145349-A2 SUBSTITUTED PYRROLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-12-21 WO disclosed
WO-2007145349-A2 SUBSTITUTED PYRROLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-12-21 WO disclosed
EP-1824841-A1 SUBSTITUTED PYRROLE DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2007-08-29 EP disclosed
WO-2006064944-A1 SUBSTITUTED PYRROLE DERIVATIVE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190713-A1 FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF MKNK2, CYP2J2, PTGS2 KIF11 227/4885MMP3 3583/4885ALDH1A1 4091/4885
US-20080176906-A1 Substituted Pyrrole Derivative AR, NR5A1, MC2R KIF11 3224/4885MMP3 3456/4885ALDH1A1 408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.